Indications
For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2)
Composition
- Active substance
- porcine circovirus type 2 ORF2 protein
- International name (INN)
- porcine circovirus vaccine (inactivated)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ingelvac PCV FLEX
- Active substance
- porcine circovirus type 2 ORF2 protein
- Group
- Veterinary medicines
- Marketing authorisation holder
- Boehringer Ingelheim Vetmedica GmbH
- Status
- Withdrawn
- EU authorisation
- 24 May 2017